Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by biorunon Jul 07, 2022 8:31am
423 Views
Post# 34807756

The shorts have left the building

The shorts have left the building If you reconcile the IROCC report which came out end of June with the update today from CEO.ca, you will note there were over 160 short sale trades with a volume position of 835k shares. Today on CEO.CA, they reported the number has dropped to 104k only (from 535k~ previous 2 week report period first two weeks of june)

so the tree cutters were here and now appear to have squeezed the lemon again and left. some may still be desperately trying to close off the 104k as we speak.

so my question to all of you (specifically the ones who seem ill intent on deliberately defaming the reputation of both the recent deal with Abbvie  and the company) is are you happy with the results over the last week or so? do you see how you have all directly and deliberately contributed to this, and you continue to complain?


https://www.iiroc.ca/sites/default/files/epubs/SSALE/20220616-20220630_ShortSaleTradingSummaryReport.csv?1656680102

<< Previous
Bullboard Posts
Next >>